Irritable Bowel Syndrome with Diarrhea
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing nitazoxanide and rifaximin in adults with irritable bowel syndrome with diarrhea has been withdrawn.
-
EMA withdrawal · 2021-02-25EMA Withdrawn: Truberzi (eluxadoline) — Allergan Pharmaceuticals International Limited
The EMA has withdrawn Truberzi (eluxadoline) from the market for irritable bowel syndrome with diarrhea.
-
CLINICAL_TRIALS withdrawal · 2017-06-20Clinical Trial Update: Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction [NA]
A trial of Saccharomyces cerevisiae CNCM I-3856 for irritable bowel syndrome with diarrhea and post-infectious bowel dysfunction has been wi…
-
CLINICAL_TRIALS withdrawal · 2016-05-19Clinical Trial Update: 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]
A Phase 3 trial evaluating ibodutant for irritable bowel syndrome with diarrhea in women has been withdrawn.